Institutional Ownership
Sarepta Therapeutics Inc
CUSIP 803607AD2NOTE 1.250% 9/1SRPTQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
6
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bnp Paribas Asset Management Holding S.A. | 3.50M | $3.22M |
| 2 | Financial Consulate, Inc | 999.0K | $920.3K |
| 3 | Hb Wealth Management, LLC | 555.0K | $511.0K |
| 4 | Wealthspire Advisors, LLC | 27.0K | $24.9K |
| 5 | Rothschild Investment LLC | 1.0K | $919 |
| 6 | Cambridge Investment Research Advisors, Inc. | 13.0K | $12 |